Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 21, 2017

View Archived Issues

GD116 demonstrates enhanced antitumor efficacy in human breast cancer models

U.S. Dept. of Health & Human Services describes FLT3-specific chimeric antigen receptors

EpiVax receives grant to develop therapy for Graves disease

Promising phase I data for CK-2127107 in healthy subjects

Rhizen's tenalisib given orphan drug designation for peripheral T-cell lymphoma

FDA gives Cu(II)-ATSM orphan drug status for ALS

Eloxx Pharmaceuticals and Sevion Therapeutics complete acquisition

JSR Corporation to acquire Crown Bioscience International

Novel SCN2A gene mutations tied to intractable epilepsy

First clinical results reported for CAR T cells targeting CD123

Ticagrelor well tolerated in phase II pediatric sickle cell disease trial

Loxo Oncology starts rolling NDA submission for larotrectinib

TARIS and BMS agree to test combination therapy for muscle invasive bladder cancer

Arrowhead Pharmaceuticals applies to conduct first-in-human study of ARO-AAT

Cadent Therapeutics identifies novel potassium channel modulators

New parkin modulators divulged by An2H Discovery

The University of Texas discloses novel SHP-2 inhibitors

NuCana BioMed discovers new cladribine derivatives

FDA approves Macrilen for diagnosis of adult growth hormone deficiency

FDA expands Opdivo indication

FDA approves Perjeta for adjuvant treatment of HER2-positive early breast cancer

AbbVie reports topline results from phase III study of upadacitinib

Aivita initiates phase II autologous cancer immunotherapy study in ovarian cancer

FDA grants QIDP designation to ceftobiprole for S. aureus bacteremia

FDA accepts Seysara NDA for moderate to severe acne

UCB reports phase IIb data on bimekizumab in psoriatic arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...